» Articles » PMID: 1819751

Studies on the Selectivity of Enzymes Involved in Platelet-activating Factor Formation in Stimulated Cells

Overview
Journal Lipids
Specialty Biochemistry
Date 1991 Dec 1
PMID 1819751
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The present studies were undertaken to obtain further insight into the selectivities of the enzymes, i.e., phospholipase A2 and acetyltransferase, involved in platelet-activating factor (PAF) production upon stimulation of human polymorphonuclear leukocytes (PMN) and platelets. After appropriate stimulation of the cells in the presence of [3H]acetate the total PAF and analogs, i.e., 1-alkyl-2-acetyl-, 1-alkenyl-2-acetyl-, and 1-acyl-2-acetyl-glycero-3- phosphocholine were isolated by high performance liquid chromatography. The isolated mixture was subjected to treatment with phospholipase A1 to differentiate acetate incorporation into 1-ether linked and 1-ester linked species. The ratio of acetate incorporation into 1-ether linked vs 1-ester linked PAF analogs amounted to 13.8 +/- 1.0 and 1.3 +/- 0.1 for PMN and platelets, respectively. When compared to the ratio of 1-ether linked and 1-ester linked species in the diradylglycerophosphocholine precursors in each cell type, i.e., 1.13 for PMN and 0.22 for platelets, these data suggested a pronounced selectivity for the phospholipase A2 and/or acetyltransferase in the process of PAF production. When the experiments were repeated with cells that had been pretreated with phenylmethanesulfonylfluoride (PMSF) to block the acetylhydrolase, the most dramatic effects were observed on acetate incorporation into 1-acyl-2-acetyl-glycero-3-phosphocholine, which increased much more than that into 1-alk(en)yl-2-acetyl-glycero-3-phosphocholine. Under these conditions, the ratio of acetate incorporation into 1-ether linked vs 1-ester linked PAF analogs became 1.4 +/- 0.2 and 0.17 +/- 0.02 for PMN and platelets, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Enzymes of platelet activating factor synthesis in brain.

Baker R Neurochem Res. 1995; 20(11):1345-51.

PMID: 8786821 DOI: 10.1007/BF00992510.


Platelet-activating factor: the biosynthetic and catabolic enzymes.

Snyder F Biochem J. 1995; 305 ( Pt 3):689-705.

PMID: 7848265 PMC: 1136314. DOI: 10.1042/bj3050689.

References
1.
Nakagawa Y, Kurihara K, Sugiura T, WAKU K . Heterogeneity in the metabolism of the arachidonoyl molecular species of glycerophospholipids of rabbit alveolar macrophages. The interrelationship between metabolic activities and chemical structures of the arachidonoyl molecular species. Eur J Biochem. 1985; 153(2):263-8. DOI: 10.1111/j.1432-1033.1985.tb09296.x. View

2.
Blank M, Snyder F . Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids. J Chromatogr. 1983; 273(2):415-20. DOI: 10.1016/s0378-4347(00)80963-9. View

3.
Sturk A, Schaap M, Ten Cate J, Heymans H, Schutgens R, Przyrembel H . Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. J Clin Invest. 1987; 79(2):344-50. PMC: 424069. DOI: 10.1172/JCI112818. View

4.
Satouchi K, Oda M, Yasunaga K, Saito K . Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor. Biochem Biophys Res Commun. 1985; 128(3):1409-17. DOI: 10.1016/0006-291x(85)91097-6. View

5.
Sturk A, Schaap M, Prins A, Ten Cate J, van den Bosch H . Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. Biochim Biophys Acta. 1989; 993(2-3):148-56. DOI: 10.1016/0304-4165(89)90157-8. View